IGF2BP2 and neoplasm of hypopharynx: Therefore, as with PD-L1 inhibition, IGF2BP2 knockdown may inhibit PD-1 expression via binding to PD-L1 mRNA, ultimately reducing the progression of hypopharyngeal neoplasms.